Recent data from the Hong Kong Stock Exchange reveals that on July 10th, JPMorgan Chase & Co. increased its holding in Pharmaron (HKEX: 03759) by approximately 1.29114 million shares.
The transaction was executed at an average price of about HK$22.1068 per share, resulting in a total investment of roughly HK$28.543 million.
Following this acquisition, JPMorgan's total shareholding in the company now stands at approximately 26.3828 million shares, representing a stake of about 7.32%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments